Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's.
Monitoring serum S100B levels may reduce exposure to cranial CT scans, thereby reducing their number, in children with mild head trauma when a clinical decision algorithm is followed.
Outcomes were similar with each intervention overall, but the medication appeared to produce better outcomes in women with a cervical length of 25 mm or less.